Sweet Diabetes Foundation
About Sweet Diabetes Foundation
Data last updated:
Sweet Diabetes Foundation is a private not for profit company based in Chandigarh, India. It operates in the social services and community development segment of the non-profit sector. It was incorporated on 17 May 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U85300CH2019NPL042528.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sachin Mittal and Shiba Mittal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO 174 – 175 Ff Sector 9 – C, Chandigarh, India – 160009.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.24 Cr, a growth of 59% compared to the previous year. For the same year it recorded a net profit of ₹13.71 Lakh (net margin 11.1%) and EBITDA of ₹14.79 Lakh (EBITDA margin 11.9%). Revenue has grown at a compounded annual rate (CAGR) of 386% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sweet Diabetes Foundation's registered office is in Chandigarh, Chandigarh. Its e-mail address is in the company report.
- Email
- Registered AddressSCO 174 – 175 Ff Sector 9 – C, Chandigarh, India – 160009
- IndustryNon-Profit Organizations, Social Work
To see the full contact details of Sweet Diabetes Foundation, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sweet Diabetes Foundation is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Sweet Diabetes Foundation, buy the company report.
Financials of Sweet Diabetes Foundation
FY 2025 filings availableSweet Diabetes Foundation reported revenue of ₹1.24 Cr (up 59% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 386% over three years, including 59% growth in the latest year. EBITDA rose 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.79 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.71 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.9% | ||||
| Net Profit Margin | 11.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sweet Diabetes Foundation, buy the company report.
Board of directors of Sweet Diabetes Foundation
Sweet Diabetes Foundation has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sachin Mittal | Director | 17 May 2019 | 7 Years 5 Months | Current |
| Shiba Mittal Also directs: Sry Health and Wellness Private Limited | Director | 17 May 2019 | 7 Years 5 Months | Current |
| Sumati Jyoti | Additional Director | 14 Feb 2025 | 1 Years 8 Months | Current |
| Ankita Gupta | Additional Director | 14 Feb 2025 | 1 Years 8 Months | Current |
Peer comparison
Sweet Diabetes Foundation is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Yashoda Institute of Medical Sciences Private Limited | ₹1.24 Cr (FY 2025) | Hyderabad, Telangana, India | ||||
| Waloray Pharma Private Limited | ₹1.24 Cr (FY 2025) | -4.0% | Thanjavur, Tamil Nadu, India | |||
| Lomrod Pharmaceuticals Private Limited | ₹1.24 Cr (FY 2025) | 47.0% | Jaipur, Rajasthan, India | |||
| Gauri Kaul Foundation | ₹1.24 Cr (FY 2024) | -5.0% | Delhi, India | |||
| Quantumlife Sciences Private Limited | ₹1.24 Cr (FY 2025) | 199.0% | Noida, Uttar Pradesh, India | |||
| Sweet Diabetes Foundationthis company | ₹1.24 Cr (FY 2025) | ₹13.71 Lakh | 11.1% | 59.0% | Chandigarh, India | |
| Ideal Fertility Ivf and Genetic Center Private Limited | ₹1.24 Cr (FY 2024) | 31.0% | Jabalpur, Madhya Pradesh, India | |||
| Inscience Healthcare Consulting Private Limited | ₹1.24 Cr (FY 2025) | 32.0% | Bangalore, Karnataka, India | |||
| Sharvari Lab and Diagnostics Private Limited | ₹1.23 Cr (FY 2024) | Hyderabad, Telangana, India | ||||
| Koshi Arogya Hospital Private Limited | ₹1.23 Cr (FY 2025) | -7.0% | Purnia, Bihar, India | |||
| Anzit Pharmaceuticals Private Limited | ₹1.23 Cr (FY 2024) | 59.0% | Pune, Maharashtra, India |
To see the full peer comparison of Sweet Diabetes Foundation, buy the company report.
Legal cases
No court or tribunal cases involving Sweet Diabetes Foundation are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sweet Diabetes Foundation; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sweet Diabetes Foundation; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sweet Diabetes Foundation has 4 board changes on record since 2019: 4 appointments. The latest: Ankita Gupta was appointed as Additional Director on 14 Feb 2025.
Frequently asked questions
Sweet Diabetes Foundation is an active private not for profit company based in Chandigarh, India. The company works in social work, within the non-profit organizations industry. It was incorporated on 17 May 2019 (7+ years old) and is registered under CIN U85300CH2019NPL042528.
Sweet Diabetes Foundation has 4 current directors:
- Sachin Mittal - Director
- Shiba Mittal - Director
- Sumati Jyoti - Additional Director
- Ankita Gupta - Additional Director
The latest financial statements of Sweet Diabetes Foundation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Sweet Diabetes Foundation is U85300CH2019NPL042528. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sweet Diabetes Foundation was incorporated on 17 May 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Sweet Diabetes Foundation by revenue are Yashoda Institute of Medical Sciences Private Limited, Waloray Pharma Private Limited, Lomrod Pharmaceuticals Private Limited, Gauri Kaul Foundation, Quantumlife Sciences Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Ankita Gupta was appointed as Additional Director on 14 Feb 2025. Sumati Jyoti was appointed as Additional Director on 14 Feb 2025. Sachin Mittal was appointed as Director on 17 May 2019. Sweet Diabetes Foundation has 4 board changes on record in total.
The registered office of Sweet Diabetes Foundation is at SCO 174 – 175 Ff Sector 9 – C, Chandigarh, India – 160009.
Sweet Diabetes Foundation operates in the non-profit organizations industry, in the social work segment.
The compliance status of Sweet Diabetes Foundation is compliant as of 27 August 2026. The company is actively filing with the Registrar of Companies.
Sweet Diabetes Foundation can be reached at its registered office: SCO 174 – 175 Ff Sector 9 – C, Chandigarh, India – 160009.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
